Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
Public Health Action
|
November 15, 2021
High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal
S Shakya, J Edwards, H A Gupte, et al.
British Journal of Pharmacology
|
May 5, 2026
VEGFR-2 blocker induces pulmonary vascular disease in rats with CRISPR-edited human non-deficient G6PD polymorphism: role of 3D genomic modifications and DNA methylation
Christina Signoretti, Shun Matsumura, Jaser Doja, et al.
British Journal of Pharmacology
|
May 31, 2023
The severity of SARS-CoV-2 infection in K18-hACE2 mice is attenuated by a novel steroid-derivative in a gender-specific manner
Sachin A Gupte, Chandra Shekhar Bakshi, Emma Blackham, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 12, 2009
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH
Sabrina Serpillon, Beverly C Floyd, Rakhee S Gupte, et al.
The Journal of Biological Chemistry
|
May 28, 2026
Glucose-6-phosphate dehydrogenase variants modify 3D genomic organization to suppress maladaptive gene expression and vascular disease
Christina Signoretti, Shun Matsumura, Melinee D'silva, et al.
International Journal of Environmental Research and Public Health
|
December 23, 2022
High Resistance to Antibiotics Recommended in Standard Treatment Guidelines in Ghana: A Cross-Sectional Study of Antimicrobial Resistance Patterns in Patients with Urinary Tract Infections between 2017-2021
Benjamin Asamoah, Appiah-Korang Labi, Himanshu A Gupte, et al.
Journal of the American Heart Association
|
September 18, 2024
<i>G6pd</i> Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease
Christina Signoretti, Shun Matsumura, Samuel Fatehi, et al.
Public Health Action
|
November 15, 2021
High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal
R Ghimire, H A Gupte, S Shrestha, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 9, 2020
CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight Into Reduced Cardiovascular Risk Associated With Mediterranean <i>G6PD</i> Variant
Atsushi Kitagawa, Igor Kizub, Christina Jacob, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
January 9, 2020
Pluripotent hematopoietic stem cells augment α-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension
Ryota Hashimoto, Gregg M Lanier, Vidhi Dhagia, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
Public Health Action
|
November 15, 2021
High multidrug resistance in urinary tract infections in a tertiary hospital, Kathmandu, Nepal
S Shakya, J Edwards, H A Gupte, et al.
British Journal of Pharmacology
|
May 5, 2026
VEGFR-2 blocker induces pulmonary vascular disease in rats with CRISPR-edited human non-deficient G6PD polymorphism: role of 3D genomic modifications and DNA methylation
Christina Signoretti, Shun Matsumura, Jaser Doja, et al.
British Journal of Pharmacology
|
May 31, 2023
The severity of SARS-CoV-2 infection in K18-hACE2 mice is attenuated by a novel steroid-derivative in a gender-specific manner
Sachin A Gupte, Chandra Shekhar Bakshi, Emma Blackham, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 12, 2009
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH
Sabrina Serpillon, Beverly C Floyd, Rakhee S Gupte, et al.
The Journal of Biological Chemistry
|
May 28, 2026
Glucose-6-phosphate dehydrogenase variants modify 3D genomic organization to suppress maladaptive gene expression and vascular disease
Christina Signoretti, Shun Matsumura, Melinee D'silva, et al.
International Journal of Environmental Research and Public Health
|
December 23, 2022
High Resistance to Antibiotics Recommended in Standard Treatment Guidelines in Ghana: A Cross-Sectional Study of Antimicrobial Resistance Patterns in Patients with Urinary Tract Infections between 2017-2021
Benjamin Asamoah, Appiah-Korang Labi, Himanshu A Gupte, et al.
Journal of the American Heart Association
|
September 18, 2024
<i>G6pd</i> Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease
Christina Signoretti, Shun Matsumura, Samuel Fatehi, et al.
Public Health Action
|
November 15, 2021
High drug resistance among Gram-negative bacteria in sputum samples from an intensive care unit in Nepal
R Ghimire, H A Gupte, S Shrestha, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 9, 2020
CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight Into Reduced Cardiovascular Risk Associated With Mediterranean <i>G6PD</i> Variant
Atsushi Kitagawa, Igor Kizub, Christina Jacob, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
January 9, 2020
Pluripotent hematopoietic stem cells augment α-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension
Ryota Hashimoto, Gregg M Lanier, Vidhi Dhagia, et al.
Page
of 19